We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Collaboration Agreement to Bring Advanced Radiotherapy Equipment to Indonesia

By HospiMedica International staff writers
Posted on 08 Oct 2008
Cancer patients in Indonesia will gain access to sophisticated radiotherapy treatments following the signing of a Memorandum of Understanding (MOU) between Varian Medical Systems, Inc. More...
(Palo Alto, CA, USA) and Indonesia's first private cancer hospital. Under the MOU, Siloam Hospitals (Jakarta, Indonesia) and Varian have agreed to pursue a collaborative relationship to explore opportunities for developing innovative healthcare solutions for providing world-class cancer treatment in Indonesia.

The signing ceremony was carried out on September 12, 2008, by Tim Guertin, CEO of Varian Medical Systems and Dr. Mochtar Riady, founder of the Lippo Group (Jakarta, Indonesia), watched by John Heffern, deputy chief of mission at the US Embassy, Dr. Gershu Paul, CEO of Siloam Hospitals, and Prof. Susan Tai, president of the Mochtar Riady Institute for Nanotechnology (Jakarta, Indonesia).

Dr. Riady commented on the agreement, "It is wonderful for the Mochtar Riady Comprehensive Cancer Center [MRCCC] to partner with Varian Medical Systems, which is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. We are very enthusiastic about working with Varian to bring such leading technologies and therapies to Indonesia in our fight against cancer.”

The Building of Hope, which incorporates the MRCCC, is a new 29-story, 210-bed specialist hospital in central Jakarta. One of the top 10 tallest hospitals in the world, it is expected to be a major center of excellence for cancer in the Southeast Asia region when operational in December 2009. "This splendid new facility will be a landmark center and will provide Indonesia cancer patients with much-needed access to the latest and most effective forms of radiotherapy treatment,” said Tim Guertin, president and chief executive officer of Varian Medical Systems. "Varian is delighted to be working with Siloam Hospitals Group to make this very significant project a reality.”

The MRCCC, which plans to acquire two Clinac iX linear accelerators equipped with the country's first On-Board Imager devices that enable targeted image-guided radiotherapy (IGRT), will be the most fully equipped cancer center in Indonesia. IGRT is an extremely precise form of treatment that utilizes multiple imaging and motion management techniques to target tumors precisely and avoid damaging surrounding healthy tissue. Dr. Riady said, "The vision for the MRCCC is to provide an international standard private cancer and specialist hospital in Central Jakarta, using state of the art equipment that incorporates the latest generation of smart IT [information technology] systems.”

Nearly 800,000 people in Indonesia are afflicted with cancer each year but advanced cancer facilities are rare in the country.

Varian Medical Systems is a world-leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices. Varian is a major supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection.

Siloam Hospitals is investing US$500 million over the next 5-10 years to build 10 new "green-field” hospitals including Kemang Village, Bandung, and Semanggi. The Mochtar Riady Comprehensive Cancer Center at Semanggi in Central Jakarta, when completed by the end of 2009, will be Indonesia's first private Comprehensive Cancer Center and will serve the needs of thousands of Indonesians, many of whom are now traveling overseas for cancer treatments. Siloam Hospitals Lippo Karawaci (SHLK) is located around 20 km from Jakarta and is the first hospital in Indonesia to attain international hospital accreditation from US-based Joint Commission International (JCI).

Related Links:
Varian Medical Systems
Siloam Hospitals



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Exam Table
PF400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.